Weiss Multi-Strategy Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-5,000
| Closed | -$255K | – | 559 |
|
|
2018
Q1 | $255K | Buy |
+5,000
| New | +$255K | 0.01% | 412 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 552 |
|
|
2017
Q1 | – | Sell |
-20,000
| Closed | -$1.41M | – | 537 |
|
|
2016
Q4 | $1.41M | Sell |
20,000
-1,500
| -7% | -$105K | 0.07% | 216 |
|
|
2016
Q3 | $1.53M | Sell |
21,500
-370
| -2% | -$26.2K | 0.09% | 197 |
|
|
2016
Q2 | $1.07M | Sell |
21,870
-3,130
| -13% | -$153K | 0.08% | 230 |
|
|
2016
Q1 | $1.58M | Buy |
25,000
+10,000
| +67% | +$633K | 0.07% | 254 |
|
|
2015
Q4 | $1.68M | Hold |
15,000
| – | – | 0.12% | 163 |
|
|
2015
Q3 | $1.45M | Sell |
15,000
-128,432
| -90% | -$12.4M | 0.06% | 185 |
|
|
2015
Q2 | $14.7M | Hold |
143,432
| – | – | 0.58% | 36 |
|
|
2015
Q1 | $8.91M | Buy |
143,432
+2,000
| +1% | +$124K | 0.4% | 67 |
|
|
2014
Q4 | $6.21M | Hold |
141,432
| – | – | 0.21% | 91 |
|
|
2014
Q3 | $8.01M | Buy |
141,432
+62,232
| +79% | +$3.52M | 0.2% | 116 |
|
|
2014
Q2 | $3.56M | Buy |
79,200
+3,850
| +5% | +$173K | 0.08% | 221 |
|
|
2014
Q1 | $3.68M | Buy |
+75,350
| New | +$3.68M | 0.07% | 236 |
|